Vaccines and Preventable Diseases:
Varicella Vaccine Effectiveness and Duration of Protection
Information for Health Care Providers
One dose
- 1 dose of single-antigen varicella vaccine is—
- 85% effective at preventing any form of varicella
- almost 100% effective against severe varicella
Two doses
- In a pre-licensure clinical trial, 2 doses of vaccine were—
- 98% effective at preventing any form of varicella
- 100% effective against severe varicella
- In post-licensure studies, 2 doses of vaccine were—
- 88% to 98% effective at preventing all varicella
In Children with HIV-infection
- 1 dose of single-antigen varicella vaccine is—
- 82% effective at preventing any form of varicella
It is not known how long a vaccinated person is protected against varicella. But, live vaccines in general provide long-lasting immunity.
- Several studies have shown that people vaccinated against varicella had antibodies for at least 10 to 20 years after vaccination. But, these studies were done before the vaccine was widely used and when infection with wild-type varicella was still very common.
- A case-control study conducted from 1997 to 2003 showed that 1 dose of varicella vaccine was 97% effective in the first year after vaccination and 86% effective in the second year. From the second to eighth year after vaccination, the vaccine effectiveness remained stable at 81 to 86%. Most vaccinated children who developed varicella during the 8 years after vaccination had mild disease.(1)
- A clinical trial showed that children with 2 doses of varicella vaccine were protected 10 years after being vaccinated. Fewer people had breakthrough varicella after 2 doses compared with 1 dose. The risk of breakthrough varicella did not increase over time.(2)
(1)Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness over time of varicella vaccine. JAMA. 2004 Feb 18;291(7):851-5.
(2)Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132–7.
- Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, et al. Effectiveness of 2 doses of varicella vaccine in children
. J Infect Dis. 2011 Feb;203(3):312-5. - Son M, Shapiro ED, LaRussa P, Neu N, Michalik DE, Meglin M, et al. Effectiveness of varicella vaccine in children infected with HIV
. J Infect Dis. 2010 Jun 15;201(12):1806-10. - Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients—Arkansas, 2006
. Pediatr Infect Dis J. 2009 Aug;28(8):678-81. - Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges
. Pediatrics. 2008 Sep;122(3):e744-51. Review. - Seward JF, Marin M, Vasquez M. Varicella vaccine effectiveness in the United States vaccination program: a review
. J Infect Dis (Suppl). 2008 Mar 1;197 Suppl 2:S82-9. Review. - Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, et al. Loss of vaccine-induced immunity to varicella over time
. N Engl J Med. 2007 Mar 15;356(11):1121-9. - Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine
. Pediatr Infect Dis J. 2004;23:132-7. - Vázquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, Shapiro ED. Effectiveness over time of varicella vaccine
. JAMA. 2004 Feb 18;291(7):851-5. - Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children
. Pediatrics. 1997;100:761-6. - Asano Y, Suga S, Yoshikawa T, Kobavashi I, Yazaki T, Shibata M, et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine
. Pediatrics. 1994;94:524-6.
- Prevention of Varicella—Recommendations of the Advisory Committee on Immunization Practices MMWR. 2007.
- Conducting Varicella Surveillance
- Monitoring the Impact of Varicella Vaccination
Return to main Varicella Vaccination page
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Content last reviewed on August 30, 2012
Content Source: National Center for Immunization and Respiratory Diseases